T Cell-Dependent Antibody Response Tests

Immunotoxicology Strategies for Pharmaceutical Safety Assessment

Volumn , Issue , 2008, Pages 65-76

  Piccotti, Joseph R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Immunotoxicity assessment application; T cell dependent antibody response tests; TDAR assay predicting immunotoxicity hazard

Indexed keywords

EID: 79960997891     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470386385.ch6     Document Type: Chapter

References (27)

1. CPMP (Committee for Proprietary Medicinal Products). Note for Guidance on Repeated Dose Toxicity. CPMP/SWP/1042/99, 2000.
2. Dean JH, Luster MI, Boorman GA, Lauer LAD, Leubke RW, Lawson L. Selective immunosuppression resulting from exposure to the carcinogenic congener of benzopyrene in B6C3F1 mice. Clin Exp Immunol 1983;52:199-206.
3. Descotes J. Methods of evaluating immunotoxicity. Expert Opin Drug Metab Toxicol 2006;2(2):249-259.
4. Descotes G, Pinard D, Gallas J-F, Penacchio E, Blot C, Moreau C. Extension of the 4-week safety study for detecting immune system impairment appears not necessary:examples of cyclosporin A in rats. Toxicology 1996;112:245-256.
5. FDA (Food and Drug Administration, Center for Drug Evaluation and Research). Guidance for Industry. Immunotoxicology Evaluation of Investigational New Drugs, 2002.
6. Finco-Kent D, Kawabata TT. Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluation. J Immunotoxicol 2005;2:197-201.
7. Gore ER. Immune function tests for hazard identification:a paradigm shift in drug development. Basic Clin Pharmacol Toxicol 2006;98:331-335.
8. Gore ER, Gower J, Kurali E, Sui J-L, B ynum J, E nnulat D, H erzyk DJ. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation. Toxicology 2004;197:23-35.
9. Guilbert B, Dighiero G, Avrameas S. Naturally-occurring antibodies against nine common antigens in human sera. I. Detection, isolation, and characterization. J Immunol 1982;128:2779-2787.
10. ICH (International Conference on Harmonization). Guidance for Industry. S8 Immunotoxicity Studies for Human Pharmaceuticals, 2006.
11. ICICIS Group Investigators. Report of validation study of assessment of direct immunotoxicology in the rat. Toxicology 1998;125:183-201.
12. Jerne NK, Nordin AA. Plaque formation in agar by single antibody-producing cells. Science 1963;140:405.
13. Johnson CW, Williams WC, Copeland CB, DeVito MJ, Smialowicz RJ. Sensitivity of the SRBC PFC assay versus ELISA for detection of immunosuppression by TCDD and TCDD-like congeners. Toxicology 2000;156:1-11.
14. Kim CJ, Berlin JA, Bugelski PJ, Haley P, Herzyk DJ. Comparison of immune functional tests using T-dependent antigens in immunotoxicology studies:a meta-analysis. Per Exp Clin Immunotox 2007;1:60-73.
15. Korver K, Zeijlemaker WP, Schellekens PTA, Vossen JM. Measurement of primary in vivo IgM-and IgG-antibody response to KLH in humans:implications of pre-immune IgM binding in antigen-specific ELISA. J Immunol Methods 1984;74:241-251.
16. Ladics GS, Smith C, Heaps K, Elliott GS, Slone TW, Loveless SE. Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study. Toxicology 1995;96:225-238.
17. Ladics GS, Smith C, Elliott GS, Slone TW, Loveless SE. Further evaluation of the incorporation of an immunotoxicological function assay for assessing humoral immunity for hazard identification purposes in rats in a standard toxicology study. Toxicology 1998;126:137-152.
18. Luster MI, Portier C, Pait DG, White KL, Gennings C, Munson AE, Rosenthal GJ. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 1992;18:200-210.
19. Mishell RI, Dutton RW. Immunization of dissociated spleen cell cultures from normal mice. J Exp Med 1967;126:423-442.
20. Piccotti JR, Alvey JD, Reindel JF, Guzman RE. T-cell-dependent antibody response:assay development in cynomolgus monkeys. J Immunotoxicol 2005;2:191-196.
21. Smith HW, Winstead CJ, Stank KK, Halstead BW, Wierda D. A predictive F344 rat immunotoxicology model:cellular parameters combined with humoral responses to NP-C γ G and KLH. Toxicology 2003;194:129-145.
22. Soos JM, Rodd M, Polsky RM, Keegan SP, Bugelski P, Herzyk DJ. Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species. Clin Immunol 2003;109:188-196.
23. Temple L, Kawabata TT, Munson AE, White KL. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam Appl Toxicol 1993;21:412-419.
24. Ulrich P, Paul G, Perentes E, Mahl A, Roman D. Validation of immune function testing during a 4-week oral toxicity study with FK506. Toxicol Lett 2004;149:123-131.
25. Vos JG, Van Loveren H. Experimental studies of immunosuppression:how do they predict for man ? Toxicology 1998;129:13-26.
26. Weaver JL, Tsutsui N, Hisada S, Vidal J-M, S panhaak S, S awada J, H asting KL, van der Laan JW, Van Loveren H, Kawabata TT, Sims J, Durham SK, Fueki O, Matula TI, Kusunoki H. Meeting report:development of the ICH guidelines for immunotoxicology evaluation of pharmaceuticals using a survey of industry practices. J Immunotoxicol 2005;2:171-180.
27. Wilson SD, Munson AE, Meade BJ. Assessment of the functional integrity of the humoral immune response:the plaque-forming cell assay and the enzyme-linked immunosorbent assay. Methods 1999;19:3-7.